Point of Care Testing Market by Mode (Prescription-based Testing and OTC-based Testing, etc)
Access full Research: https://www.renub.com/point-of-care-testing-market-and-forecast-to-2016-global-analysis-158-p.php Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Point of Care Testing Market is expected to witness substantial growth due to rising incidence of chronic diseases; rapidly growing middle class population in developing countries like China & India, Continued Expansion of Point of Care Including Self Testing and New Evolution in Point of Care Testing further boosts the demand for the industry over the forecast period. Request a free sample copy of the report: https://www.renub.com/contactus.php Renub Research report titled “Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson)” provides a complete analysis of Point of Care Testing Market. By Diagnostics - Blood Glucose and Infectious Disease controls the Point of Care Testing Market The report studies the market of the following Diagnostics segments: Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker.
★
★
★
★
★
183 views • 12 slides
